Lv41
490 积分 2025-08-06 加入
[Chinese guidelines for diagnosis and treatment of myelodysplastic neoplasms (2026)]
8天前
已完结
RAS Pathway Activation and Microenvironmental Adaptation as Hallmarks of Myeloid Sarcoma
21天前
已完结
A multicenter real-world study of clinical outcomes in octogenarians and older patients with acute myeloid leukemia
22天前
已完结
Musculoskeletal Myeloid Sarcoma: Clinical, Imaging, Management, and Outcomes in 41 Adult Patients
27天前
已完结
Venetoclax‐Based Regimens in Newly Diagnosed FLT3‐Mutated Older or Unfit Acute Myeloid Leukemia: A Systematic Review and Meta‐Analysis of Comparative and Single‐Arm Outcomes
1个月前
已完结
[Expert consensus on the diagnosis and treatment of pediatric acute myeloid leukemia (2024)]
1个月前
已完结
Comparison of venetoclax and azacitidine versus a cytarabine‐based treatment for patients with acute myeloid leukaemia in first relapse after chemotherapy. A real‐world study of the DATAML ‐ IPC ‐ AURAML consortium
1个月前
已完结
Quizartinib plus chemotherapy in newly diagnosed patients with FLT3-internal-tandem-duplication-positive acute myeloid leukaemia (QuANTUM-First): a randomised, double-blind, placebo-controlled, phase 3 trial
1个月前
已完结
Sorafenib maintenance after allogeneic haemopoietic stem-cell transplantation in patients with FLT3-ITD acute myeloid leukaemia: long-term follow-up of an open-label, multicentre, randomised, phase 3 trial
1个月前
已完结
Azacitidine plus venetoclax in patients with high-risk myelodysplastic syndromes or chronic myelomonocytic leukaemia: phase 1 results of a single-centre, dose-escalation, dose-expansion, phase 1–2 study
2个月前
已完结
皖公网安备34019202002308
